AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29771567 — intervention group
Group type: EXPERIMENTAL
Intervention: Enacting a ritual before a food choice
Number of subjects: 6
Study 29771567 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritualized gestures not explicitly labeled as a ritual
Number of subjects: 6
Study 29771567 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituals in prosocial decision-making
Number of subjects: 6
Study 29771567 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituals affecting responses to self-control conflicts
Number of subjects: 6
Study 27258430 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based HIV counselling and testing (HBHCT) with immediate referral to TasP clinics for ART
Number of subjects: 1323
Study 27258430 — intervention group
Group type: COMPARATOR
Intervention: Home-based HIV counselling and testing (HBHCT) with referral according to national guidelines
Number of subjects: 1323
Study 27258430 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based HIV counselling and testing (HBHCT)
Number of subjects: 1323
Study 24430001 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose, transdermal 17β-estradiol
Number of subjects: 571
Study 24430001 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral conjugated equine estrogen
Number of subjects: 571
Study 24430001 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 571
Study 22541797 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination with TSOL16 and TSOL18 (200 μg each, plus 5mg Quil‐A)
Number of subjects: 137
Study 22541797 — intervention group
Group type: COMPARATOR
Intervention: Control group (unvaccinated pigs)
Number of subjects: 137
Study 20167888 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience Corps participation in volunteer roles in public schools designed to increase healthy behaviors.
Number of subjects: 155
Study 18605851 — intervention group
Group type: EXPERIMENTAL
Intervention: Availability of an attractive alternative (AA) relationship partner
Number of subjects: 7
Study 18605851 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intention induction
Number of subjects: 7
Study 16079444 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine (0.5%)
Number of subjects: 60
Study 16079444 — intervention group
Group type: COMPARATOR
Intervention: Standard care (lidocaine)
Number of subjects: 60
Study 12429158 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicalutamide (B)
Number of subjects: 220
Study 12429158 — intervention group
Group type: COMPARATOR
Intervention: Goserelin plus flutamide (G+F)
Number of subjects: 220
Study 10720834 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sodium phosphate
Number of subjects: 256
Study 10720834 — intervention group
Group type: COMPARATOR
Intervention: Picolax
Number of subjects: 256
Study 8795875 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 1594212 — intervention group
Group type: EXPERIMENTAL
Intervention: Disposable latex cover over the pneumotonometer tip
Number of subjects: 187
Study 1594212 — intervention group
Group type: COMPARATOR
Intervention: Uncovered pneumotonometer tip
Number of subjects: 187
Study 6732270 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 0
Study 6732270 — intervention group
Group type: COMPARATOR
Intervention: Salicylates
Number of subjects: 0
Study 31343124 — intervention group
Group type: EXPERIMENTAL
Intervention: CXA-10 150 mg
Number of subjects: 0
Study 31343124 — intervention group
Group type: EXPERIMENTAL
Intervention: CXA-10 coadministration
Number of subjects: 0
Study 31343124 — intervention group
Group type: EXPERIMENTAL
Intervention: CXA-10 (all doses)
Number of subjects: 0
Study 31343124 — intervention group
Group type: EXPERIMENTAL
Intervention: CXA-10
Number of subjects: 0
Study 30123047 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser therapy at 658 nm
Number of subjects: 67
Study 30123047 — intervention group
Group type: COMPARATOR
Intervention: Laser therapy at 940 nm
Number of subjects: 67
Study 30123047 — intervention group
Group type: COMPARATOR
Intervention: Laser therapy at 808 nm
Number of subjects: 67
Study 30123047 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy (control group)
Number of subjects: 67
Study 26801148 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (Group 1)
Number of subjects: 43
Study 26801148 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycle ergometer training (Group 2)
Number of subjects: 43
Study 26801148 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycle ergometer and inspiratory muscle training (Group 3)
Number of subjects: 43
Study 26801148 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group 4)
Number of subjects: 43
Study 25230735 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week inter-donation interval
Number of subjects: 50000
Study 25230735 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week inter-donation interval
Number of subjects: 50000
Study 25230735 — intervention group
Group type: COMPARATOR
Intervention: 12-week inter-donation interval
Number of subjects: 50000
Study 25230735 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-week inter-donation interval
Number of subjects: 50000
Study 25230735 — intervention group
Group type: COMPARATOR
Intervention: Standard 16-week inter-donation interval
Number of subjects: 50000
Study 25230735 — intervention group
Group type: EXPERIMENTAL
Intervention: Donor quality of life assessed using the Short Form Health Survey
Number of subjects: 50000
Study 25230735 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferrals due to low haemoglobin and other factors
Number of subjects: 50000
Study 25230735 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron status
Number of subjects: 50000
Study 25230735 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive function
Number of subjects: 50000
Study 25230735 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 50000
Study 25230735 — intervention group
Group type: EXPERIMENTAL
Intervention: Donor attitudes
Number of subjects: 50000
Study 23157894 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Start to Pregnancy workshop
Number of subjects: 360
Study 23157894 — intervention group
Group type: COMPARATOR
Intervention: Usual care (nutrition resource)
Number of subjects: 360
Study 21044293 — intervention group
Group type: EXPERIMENTAL
Intervention: CT examinations of the chest and upper abdomen
Number of subjects: 29900000
Study 21044293 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower abdominal CT
Number of subjects: 29900000
Study 21044293 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual effective dose per capita for Japan
Number of subjects: 29900000
Study 21044293 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual collective effective dose in Japan
Number of subjects: 29900000
Study 21044293 — intervention group
Group type: EXPERIMENTAL
Intervention: CT examinations
Number of subjects: 29900000
Study 17356942 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet enriched with arginine, omega-3 fatty acids, and ribonucleic acid (RNA) for 6 days preoperatively, followed by the same diet postoperatively.
Number of subjects: 28
Study 17356942 — intervention group
Group type: COMPARATOR
Intervention: Low-fiber diet for 6 days preoperatively, followed by restoration of oral nutrition on postoperative day 3.
Number of subjects: 28
Study 15863547 — intervention group
Group type: EXPERIMENTAL
Intervention: Isopropanolic black cohosh extract (40 mg daily for 12 weeks)
Number of subjects: 304
Study 15863547 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matching tablets)
Number of subjects: 304
Study 11717642 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic cerclage with bed rest
Number of subjects: 35
Study 11717642 — intervention group
Group type: COMPARATOR
Intervention: Bed rest alone
Number of subjects: 35
Study 9228509 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin aspart (0.2 U/kg body weight)
Number of subjects: 17
Study 9228509 — intervention group
Group type: COMPARATOR
Intervention: U40 insulin (0.2 U/kg body weight)
Number of subjects: 17
Study 9228509 — intervention group
Group type: COMPARATOR
Intervention: U100 soluble insulin
Number of subjects: 17
Study 8127293 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 0
Study 3476002 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental ascorbic acid 500 mg
Number of subjects: 52
Study 3476002 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental ascorbic acid 1000 mg
Number of subjects: 52
Study 3476002 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 2198977 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular depot methylprednisolone acetate (120 mg)
Number of subjects: 59
Study 2198977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 31887168 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischaemic conditioning (RIC)
Number of subjects: 225
Study 31887168 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 225
Study 27363929 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 IU every 2 weeks for 12 weeks)
Number of subjects: 60
Study 26003873 — intervention group
Group type: EXPERIMENTAL
Intervention: ABM
Number of subjects: 65
Study 23053132 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive unilateral neuromuscular training (IUNT) focusing on the non-dominant side of the low back for 8 weeks.
Number of subjects: 16
Study 23053132 — intervention group
Group type: COMPARATOR
Intervention: Regular training (control group) for 8 weeks.
Number of subjects: 16
Study 21586444 — intervention group
Group type: EXPERIMENTAL
Intervention: Airtraq® laryngoscope
Number of subjects: 90
Study 21586444 — intervention group
Group type: COMPARATOR
Intervention: C‐MAC® laryngoscope
Number of subjects: 90
Study 21586444 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 90
Study 19393784 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed Enforcement Program (SEP) implemented on the freeway
Number of subjects: 0
Study 16481946 — intervention group
Group type: EXPERIMENTAL
Intervention: Single IV bolus of 500 mg of methylprednisolone
Number of subjects: 65
Study 16481946 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 14966714 — intervention group
Group type: EXPERIMENTAL
Intervention: Unstable support surface with trunk stability task
Number of subjects: 20
Study 14966714 — intervention group
Group type: EXPERIMENTAL
Intervention: Unstable support surface with head tracking task
Number of subjects: 20
Study 14966714 — intervention group
Group type: EXPERIMENTAL
Intervention: Unstable support surface with object grasping task
Number of subjects: 20
Study 14966714 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 20
Study 14966714 — intervention group
Group type: COMPARATOR
Intervention: Patients with multiple sclerosis
Number of subjects: 20
Study 11393591 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (10 mg/day)
Number of subjects: 469
Study 11393591 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg/day)
Number of subjects: 469
Study 11393591 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 469
Study 9232707 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for functional gastrointestinal disorders over a four-week period
Number of subjects: 615
Study 8127946 — intervention group
Group type: EXPERIMENTAL
Intervention: d,l‐fenfluramine (60 mg PO)
Number of subjects: 7
Study 8127946 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 3609114 — intervention group
Group type: EXPERIMENTAL
Intervention: Endralazine 5 mg administered before breakfast
Number of subjects: 8
Study 3609114 — intervention group
Group type: COMPARATOR
Intervention: Endralazine 5 mg administered after breakfast
Number of subjects: 8
Study 3609114 — intervention group
Group type: EXPERIMENTAL
Intervention: Endralazine 10 mg administered before breakfast
Number of subjects: 8
Study 3609114 — intervention group
Group type: COMPARATOR
Intervention: Endralazine 10 mg administered after breakfast
Number of subjects: 8
Study 29181658 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric citrate hydrate (FCH)
Number of subjects: 40
Study 29181658 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium ferrous citrate (SFC)
Number of subjects: 40
Study 29181658 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 28497058 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive handwashing promotion
Number of subjects: 253
Study 28497058 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 253
Study 25638248 — intervention group
Group type: EXPERIMENTAL
Intervention: nab-paclitaxel plus gemcitabine
Number of subjects: 861
Study 25638248 — intervention group
Group type: COMPARATOR
Intervention: gemcitabine alone
Number of subjects: 861
Study 23190184 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Methotrexate (PO MTX) 25 mg
Number of subjects: 11
Study 23190184 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous Methotrexate (SC MTX) 25 mg
Number of subjects: 11
Study 23190184 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of PO and SC MTX
Number of subjects: 11
Study 21261406 — intervention group
Group type: EXPERIMENTAL
Intervention: CRA plus vouchers
Number of subjects: 64
Study 21261406 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 64
Study 19922572 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal naloxone (2 mg)
Number of subjects: 172
Study 19922572 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular naloxone (2 mg)
Number of subjects: 172
Study 16500494 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 57
Study 16500494 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler-derived LV filling indices
Number of subjects: 57
Study 15154115 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg of rh-alpha GalA (agalsidase beta, Fabrazyme, Genzyme Corporation) biweekly for 30-36 months
Number of subjects: 58
Study 11318051 — intervention group
Group type: EXPERIMENTAL
Intervention: Priming with malleable rotating objects
Number of subjects: 0
Study 11318051 — intervention group
Group type: EXPERIMENTAL
Intervention: Priming with rigid rotating objects
Number of subjects: 0
Study 9222729 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoalkaline phosphatase (IALP) technique
Number of subjects: 122
Study 9222729 — intervention group
Group type: COMPARATOR
Intervention: Immunofluorescence (IF) technique
Number of subjects: 122
Study 9222729 — intervention group
Group type: EXPERIMENTAL
Intervention: IALP technique (USA)
Number of subjects: 122
Study 9222729 — intervention group
Group type: EXPERIMENTAL
Intervention: IALP technique (Sweden)
Number of subjects: 122
Study 9222729 — intervention group
Group type: EXPERIMENTAL
Intervention: IALP technique (Norway)
Number of subjects: 122
Study 9222729 — intervention group
Group type: EXPERIMENTAL
Intervention: IALP technique (Italy)
Number of subjects: 122
Study 9222729 — intervention group
Group type: COMPARATOR
Intervention: IF technique (USA)
Number of subjects: 122
Study 9222729 — intervention group
Group type: COMPARATOR
Intervention: IF technique (Sweden)
Number of subjects: 122
Study 9222729 — intervention group
Group type: COMPARATOR
Intervention: IF technique (Norway)
Number of subjects: 122
Study 9222729 — intervention group
Group type: COMPARATOR
Intervention: IF technique (Italy)
Number of subjects: 122
Study 8095137 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure in vivo followed by cognitive therapy
Number of subjects: 30
Study 8095137 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy followed by exposure in vivo
Number of subjects: 30
Study 8095137 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural treatment integrating both strategies from the start
Number of subjects: 30
Study 8095137 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 30
Study 3308969 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing
Number of subjects: 90
Study 3308969 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgingival curettage
Number of subjects: 90
Study 3308969 — intervention group
Group type: COMPARATOR
Intervention: Pocket elimination surgery
Number of subjects: 90
Study 3308969 — intervention group
Group type: COMPARATOR
Intervention: Modified Widman flap surgery
Number of subjects: 90
Study 30703872 — intervention group
Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (ethyl ester form of eicosapentaenoic acid, EPA)
Number of subjects: 0
Study 30703872 — intervention group
Group type: EXPERIMENTAL
Intervention: ω‐3 fatty acid supplementation
Number of subjects: 0
Study 27056687 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed tibial platform TKA (group A)
Number of subjects: 0
Study 27056687 — intervention group
Group type: COMPARATOR
Intervention: Mobile tibial platform TKA (group B)
Number of subjects: 0
Study 25226322 — intervention group
Group type: EXPERIMENTAL
Intervention: Barbell deadlift training (twice per week for 10 weeks)
Number of subjects: 54
Study 25226322 — intervention group
Group type: EXPERIMENTAL
Intervention: Barbell deadlift training
Number of subjects: 54
Study 25226322 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study 23566308 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose beverage
Number of subjects: 20
Study 23566308 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-nutrient sweetened beverage
Number of subjects: 20
Study 21455716 — intervention group
Group type: EXPERIMENTAL
Intervention: CaD group (800 mg calcium and 10 μg vitamin D(3), n = 26)
Number of subjects: 115
Study 21455716 — intervention group
Group type: EXPERIMENTAL
Intervention: CaDK1 group (800 mg calcium, 10 μg vitamin D(3), and 100 μg vitamin K(1), n = 26)
Number of subjects: 115
Study 21455716 — intervention group
Group type: EXPERIMENTAL
Intervention: CaDK2 group (800 mg calcium, 10 μg vitamin D(3), and 100 μg vitamin K(2), n = 24)
Number of subjects: 115
Study 21455716 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual diet, n = 39)
Number of subjects: 115
Study 18377136 — intervention group
Group type: EXPERIMENTAL
Intervention: Postal questionnaire measuring cognitions about donation
Number of subjects: 4672
Study 18377136 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no questionnaire)
Number of subjects: 4672
Study 16828501 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone acetonide (4 mg)
Number of subjects: 43
Study 16828501 — intervention group
Group type: COMPARATOR
Intervention: Placebo (subconjunctival saline)
Number of subjects: 43
Study 12617276 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone (500 mg daily for five days with a 10-day tapering period)
Number of subjects: 109
Study 12617276 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study 11073757 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritonavir and saquinavir with stavudine
Number of subjects: 208
Study 11073757 — intervention group
Group type: COMPARATOR
Intervention: Ritonavir and saquinavir without stavudine
Number of subjects: 208
Study 11073757 — intervention group
Group type: EXPERIMENTAL
Intervention: Stavudine
Number of subjects: 208
Study 11073757 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued ARVT during LEE
Number of subjects: 208
Study 10160479 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprostadil
Number of subjects: 91
Study 10160479 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 91
Study 1470022 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive Neuromuscular Facilitation (PNF) stretching in Anterior Pelvic Tilt (APT) position
Number of subjects: 20
Study 1470022 — intervention group
Group type: EXPERIMENTAL
Intervention: Static Stretch (SS) in Anterior Pelvic Tilt (APT) position
Number of subjects: 20
Study 1470022 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive Neuromuscular Facilitation (PNF) stretching in Posterior Pelvic Tilt (PPT) position
Number of subjects: 20
Study 1470022 — intervention group
Group type: EXPERIMENTAL
Intervention: Static Stretch (SS) in Posterior Pelvic Tilt (PPT) position
Number of subjects: 20
Study 6379459 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 42
Study 6379459 — intervention group
Group type: COMPARATOR
Intervention: Prochlorperazine
Number of subjects: 42
Study 30961947 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvacrol (1.2 mg/kg/day)
Number of subjects: 21
Study 30376838 — intervention group
Group type: EXPERIMENTAL
Intervention: Matured hop extract (MHE) for 12 weeks
Number of subjects: 200
Study 30376838 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 200
Study 25688811 — intervention group
Group type: EXPERIMENTAL
Intervention: eBridge (online intervention with personalized feedback and optional online counseling)
Number of subjects: 76
Study 25688811 — intervention group
Group type: COMPARATOR
Intervention: Control condition (personalized feedback only, offered in plain report format)
Number of subjects: 76
Study 23676264 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate Mediterranean diet adherence score
Number of subjects: 6174
Study 23676264 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher monounsaturated-to-saturated fats ratio
Number of subjects: 6174
Study 23676264 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater whole grain intake
Number of subjects: 6174
Study 21414653 — intervention group
Group type: EXPERIMENTAL
Intervention: Transobturator tapes (inside-out TVT-O or outside-in TOT-ARIS)
Number of subjects: 46
Study 19729128 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodic training subjects (PTS)
Number of subjects: 30
Study 19729128 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypokinetic subjects (HKS)
Number of subjects: 30
Study 19729128 — intervention group
Group type: COMPARATOR
Intervention: Active control subjects (ACS)
Number of subjects: 30
Study 18201583 — intervention group
Group type: EXPERIMENTAL
Intervention: FDC ARV tablet for oral suspension (lamivudine 40 mg, nevirapine 70 mg, stavudine 10 mg)
Number of subjects: 36
Study 18201583 — intervention group
Group type: COMPARATOR
Intervention: Individual liquid formulations (lamivudine 10 mg/mL, nevirapine 50 mg/5 mL, stavudine 1 mg/mL)
Number of subjects: 36